MYT1L and medulloblastoma: Mutagenesis significantly increased medulloblastoma frequency and identified17 candidate cancer genes, including orthologs of genes somatically mutated(PTEN, CREBBP) or associated with poor outcome (PTEN,MYT1L) in the human disease.